Newsroom

News

SynDermix Announces Interim Changes to Leadership 20 May, 2020
Update on the Clinical Trial of the SDX-3101 Medical Device 7 April, 2020
First Site Initiation Visit (SIV) Completed for the Clinical Trial of SDX-3101 in Austria 7 January, 2020
Collaboration with King’s College London on the Formulation Development of SDX-21 1 July, 2019
AGM 2019: Re-election of Chairman and Board of Directors 11 June, 2019
SynDermix to Sell Majority Stake of SDX-Cosmetics 10 April, 2019
SynDermix Announces Changes to the Executive Team 1 April, 2019
Share Capital Increased 14 March, 2019
CHF 10 Million Investment 19 December, 2018
SDX-3103 Kick-Off Meeting, Biel 25 October, 2018

 

Upcoming Events

Swiss Biotech Day

7 September 2021

Media

SynDermix fact-sheet